Literature DB >> 3178263

Clinical presentations of Ehlers Danlos syndrome type IV.

F M Pope1, P Narcisi, A C Nicholls, M Liberman, J W Oorthuys.   

Abstract

Ehlers Danlos syndrome type IV is an often lethal disease caused by various mutations of type III collagen genes. It presents in infancy and childhood in several ways, and the symptoms and signs include low birth weight, prematurity, congenital dislocation of the hips, easy inappropriate bruising (sometimes suspected as child battering), and a diagnostic facial phenotype. These features predict a lethal adult disease often complicated by fatal arterial rupture in early or middle adult life. Most affected patients can be diagnosed from radiolabelled collagen protein profiles by polyacrylamide gel electrophoresis. Prenatal diagnosis by specific type III collagen restriction fragment length polymorphisms is possible in some families, and will become increasingly important. Prenatal diagnosis and prevention of the disease in selected families is already possible and will be widely available in the future.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178263      PMCID: PMC1779096          DOI: 10.1136/adc.63.9.1016

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  [Case of acrogeria of Gottron; place of acrogeria among various types of congenital skin atrophy].

Authors:  A BAZEX; A DUPRE
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1955 Nov-Dec

2.  Acrogeria.

Authors:  D Morris
Journal:  Proc R Soc Med       Date:  1957-05

3.  Inheritance of Ehlers-Danlos type IV syndrome.

Authors:  F M Pope; G R Martin; V A McKusick
Journal:  J Med Genet       Date:  1977-06       Impact factor: 6.318

4.  Isolation of cDNA and genomic clones encoding human pro-alpha 1 (III) collagen. Partial characterization of the 3' end region of the gene.

Authors:  M L Chu; D Weil; W de Wet; M Bernard; M Sippola; F Ramirez
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

5.  Vascular complications in the Ehlers-Danlos syndrome, with special reference to the "arterial type" or Sack's syndrome.

Authors:  A P Barabas
Journal:  J Cardiovasc Surg (Torino)       Date:  1972 Mar-Apr       Impact factor: 1.888

6.  Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.

Authors:  C A Stolle; R E Pyeritz; J C Myers; D J Prockop
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

7.  Molecular cloning and carboxyl-propeptide analysis of human type III procollagen.

Authors:  H R Loidl; J M Brinker; M May; T Pihlajaniemi; S Morrow; J Rosenbloom; J C Myers
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

8.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

  8 in total
  8 in total

1.  Spontaneous aortic rupture in a 22-year-old.

Authors:  M A Memon; C M Nicholson; J Clayton-Smith
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

Review 2.  Ehlers-Danlos syndrome has varied molecular mechanisms.

Authors:  F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

Review 3.  Prenatal diagnosis and prevention of inherited abnormalities of collagen.

Authors:  F M Pope; S C Daw; P Narcisi; A R Richards; A C Nicholls
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Occult small bowel perforation in a patient with Ehlers Danlos syndrome: a case report and review of the literature.

Authors:  Tessa Frances Leake; Tarun Singhal; Aninda Chandra; Alexandra Ashcroft; Sudeendra Doddi; Abdulzahra Hussain; Frank Smedley
Journal:  Cases J       Date:  2010-02-12

5.  Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

Authors:  U Schwarze; W I Schievink; E Petty; M R Jaff; D Babovic-Vuksanovic; K J Cherry; M Pepin; P H Byers
Journal:  Am J Hum Genet       Date:  2001-09-27       Impact factor: 11.025

6.  Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV.

Authors:  L Nuytinck; P Narcisi; A Nicholls; J P Renard; F M Pope; A De Paepe
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

7.  Skin malformations in a neonatal foal tested homozygous positive for Warmblood Fragile Foal Syndrome.

Authors:  Chloé Monthoux; Simone de Brot; Michelle Jackson; Ulrich Bleul; Jasmin Walter
Journal:  BMC Vet Res       Date:  2015-01-31       Impact factor: 2.741

8.  Spontaneous colon perforations associated with a vascular type of ehlers-danlos syndrome.

Authors:  Akira Yoneda; Kazuya Okada; Hitoshi Okubo; Mitsutoshi Matsuo; Hiroki Kishikawa; Banyar Than Naing; Atsushi Watanabe; Takashi Shimada
Journal:  Case Rep Gastroenterol       Date:  2014-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.